Research ArticleBrief Communication
Glucagon-Like Peptide-1 Versus Somatostatin Receptor Targeting Reveals 2 Distinct Forms of Malignant Insulinomas
Damian Wild, Emanuel Christ, Martyn E. Caplin, Tom R. Kurzawinski, Flavio Forrer, Michael Brändle, Jochen Seufert, Wolfgang A. Weber, Jamshed Bomanji, Aurel Perren, Peter J. Ell and Jean Claude Reubi
Journal of Nuclear Medicine July 2011, 52 (7) 1073-1078; DOI: https://doi.org/10.2967/jnumed.110.085142
Damian Wild
Emanuel Christ
Martyn E. Caplin
Tom R. Kurzawinski
Flavio Forrer
Michael Brändle
Jochen Seufert
Wolfgang A. Weber
Jamshed Bomanji
Aurel Perren
Peter J. Ell
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 52, Issue 7
July 1, 2011
Glucagon-Like Peptide-1 Versus Somatostatin Receptor Targeting Reveals 2 Distinct Forms of Malignant Insulinomas
Damian Wild, Emanuel Christ, Martyn E. Caplin, Tom R. Kurzawinski, Flavio Forrer, Michael Brändle, Jochen Seufert, Wolfgang A. Weber, Jamshed Bomanji, Aurel Perren, Peter J. Ell, Jean Claude Reubi
Journal of Nuclear Medicine Jul 2011, 52 (7) 1073-1078; DOI: 10.2967/jnumed.110.085142
Glucagon-Like Peptide-1 Versus Somatostatin Receptor Targeting Reveals 2 Distinct Forms of Malignant Insulinomas
Damian Wild, Emanuel Christ, Martyn E. Caplin, Tom R. Kurzawinski, Flavio Forrer, Michael Brändle, Jochen Seufert, Wolfgang A. Weber, Jamshed Bomanji, Aurel Perren, Peter J. Ell, Jean Claude Reubi
Journal of Nuclear Medicine Jul 2011, 52 (7) 1073-1078; DOI: 10.2967/jnumed.110.085142
Jump to section
Related Articles
Cited By...
- Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis
- Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic?
- Succinylated Gelatin Improves the Theranostic Potential of Radiolabeled Exendin-4 in Insulinoma Patients
- Molecular imaging in the investigation of hypoglycaemic syndromes and their management
- A New Theranostic Paradigm for Advanced Thyroid Cancer
- Medical management of secretory syndromes related to gastroenteropancreatic neuroendocrine tumours
- Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study
- Triple-Peptide Receptor Targeting In Vitro Allows Detection of All Tested Gut and Bronchial NETs
- Hallmarks of gastrointestinal neuroendocrine tumours: implications for treatment
- GLP-1 Provoked Severe Hypoglycemia in an Individual With Type 2 Diabetes and a Benign Insulinoma
- The Human GLP-1 Analogs Liraglutide and Semaglutide: Absence of Histopathological Effects on the Pancreas in Nonhuman Primates
- GEP-NETS update: Functional localisation and scintigraphy in neuroendocrine tumours of the gastrointestinal tract and pancreas (GEP-NETs)
- MANAGEMENT OF ENDOCRINE DISEASE: A clinical update on tumor-induced hypoglycemia
- Radiopeptide Imaging and Therapy in Europe